Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Hovering Hyalocytes: Tracking Pre-Retinal Hyalocyte Displacement in Unaffected Controls and Sickle Cell Disease (SCD) Patients Using Clinical OCT.
Author Affiliations & Notes
  • Richard B Rosen
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Affan Haq
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Luis Muncharaz Duran
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Jordan Bellis
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Maxime Centeno
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Chiemika Ihiasota
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Ritika Jhawar
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Libby Stidham
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Rishard Weitz
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Alon Harris
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Jeffery Glassberg
    Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States
    Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Toco Yuen Ping Chui
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Richard Rosen Code C(Consultant/Contractor):Visionix- Optovue, Boehringer-Ingelheim, Lumithera, CellView, Regeneron;, Code C (Consultant/Contractor), Visionix(Optovue), Ocusciences, Topcon, Canon;, Code F (Financial Support), Visionix (Optovue), Code I (Personal Financial Interest), Guardion Health, CellView, Code I (Personal Financial Interest); Affan Haq None; Luis Muncharaz Duran None; Jordan Bellis None; Maxime Centeno None; Chiemika Ihiasota None; Ritika Jhawar None; Libby Stidham None; Rishard Weitz CellView, Code E (Employment), CellView, Code I (Personal Financial Interest), CellView, Code P (Patent); Alon Harris AdOM, Qlaris, Cipla, Code C (Consultant/Contractor), AdOM, Oxymap, Qlaris, SlitLED, Code I (Personal Financial Interest), AdOM, Qlaris, Code S (non-remunerative); Jeffery Glassberg Global Blood therapeutics, Pfizer, Code C (Consultant/Contractor); Toco Chui None
  • Footnotes
    Support  R01EY027301 and R01HL159116. Additional funding for this research was provided by the Marrus Family Foundation, Challenge Grant award from Research to Prevent Blindness, and the New York Eye & Ear Foundation
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3829. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Richard B Rosen, Affan Haq, Luis Muncharaz Duran, Jordan Bellis, Maxime Centeno, Chiemika Ihiasota, Ritika Jhawar, Libby Stidham, Rishard Weitz, Alon Harris, Jeffery Glassberg, Toco Yuen Ping Chui; Hovering Hyalocytes: Tracking Pre-Retinal Hyalocyte Displacement in Unaffected Controls and Sickle Cell Disease (SCD) Patients Using Clinical OCT.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3829.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Hyalocytes are resident tissue macrophages within the vitreous involved in immune surveillance, media clarity, and response to metabolic disruptions. Once mobilized to areas of distress, they become activated, less mobile and transform. Here we demonstrate the ability to track cells over one hour using clinical OCT in normal subjects and patients with sickle cell disease, and to assess the influence of different SCD genotypes On their mobility.

Methods : Hyalocytes from 40 SCD patients (genotypes: 9 HbSC, 27 HbSS, & 4 HbS) and 24 race-matched unaffected controls were imaged at 2 sessions (baseline and 1 hour follow up) using a clinical SD-OCT device (Avanti RTVue-XR; Optovue). At each session, 10 3x3mm scans located at ∼9deg temporal to the fovea were acquired and averaged (PMID: 32574351). Hyalocytes were identified and tracked over 1 hour on a 1x1mm region of interest (Fig A1-2 & B1-2). Cell displacement was performed on an averaged 3µm OCT reflectance (OCTR) slab located above the inner limiting membrane at each session using the TrackMate plugin in ImageJ (PMID: 35654950). Cell displacements over 1 hour were then computed after the correction of OCTR scan dimension based on individual axial lengths.

Results : A total of 2041 hyalocytes were identified and tracked. Median ± interquartile range of hyalocyte displacement over 1 hour in Controls, HbSC, HbSS, and HbS were 13.58±17.86µm, 10.61±10.65 µm, 12.86±17.0 µm, and 9.87±13.25 µm, respectively. Statistical significant difference in hyalocyte displacement was found among groups (Kruskal-Wallis test, p < 0.0001). Pairwise comparisons showed no statistical significance between Controls and HbSS (p=0.586). However, HbSC and HbS showed significantly lower hyalocyte displacement, as compared to controls and HbSS (Controls vs HbSC, p<0.001; Controls vs HbS, p=0.001; HbSS vs HbSC, p=0.006 (Fig A3 & B3); HbSS vs HbS, p=0.031).

Conclusions : Hyalocyte displacement was significantly less in patients with HbSC genotype, in contrast to those from patients with HbSS. This appears consistent with the greater degree of clinical retinopathy seen in patients with HbSC compared to those with HbSS, and suggests a role for hyalocytes in sickle retinopathy. Monitoring hyalocyte mobility and distribution could be a promising strategy for evaluating level of disease activity or response to therapeutics

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×